InvestorsHub Logo
Followers 55
Posts 13535
Boards Moderated 0
Alias Born 10/12/2006

Re: None

Tuesday, 06/05/2018 4:26:04 PM

Tuesday, June 05, 2018 4:26:04 PM

Post# of 3987
Protalix BioTherapeutics Announces Additional Positive Results from Final Analysis of the Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis

https://finance.yahoo.com/news/protalix-biotherapeutics-announces-additional-positive-110000668.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News